Payden & Rygel Pfizer Inc Transaction History

Payden & Rygel

$1.16 Billion
Q4 2024

A detailed history of Payden & Rygel transactions in Pfizer Inc stock. As of the latest transaction made, Payden & Rygel holds 24,680 shares of PFE stock, worth $659,696. This represents 0.06% of its overall portfolio holdings.

Number of Shares

24,680

Previous 313,980 92.14%

Holding current value

$659,696

Previous $9.09 Million 92.79%

% of portfolio

0.06%

Previous 0.7%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$24.8 - $30.19 $7.17 Million - $8.73 Million	-289,300 Reduced 92.14%	24,680 $655,000
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $7.87 Million - $8.91 Million	284,000 Added 947.3%	313,980 $9.09 Million
Q1 2024 Oct 08, 2024	BUY	$25.89 - $29.73 $6.22 Million - $7.15 Million	240,400 Added 801.87%	270,380 $7.5 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $634,959 - $824,742	24,300 Added 427.82%	29,980 $863,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $8.83 Million - $10.2 Million	-244,590 Reduced 97.73%	5,680 $208,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $9.6 Million - $12.5 Million	-243,720 Reduced 49.34%	250,270 $10.2 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $15 Million - $19.6 Million	-359,500 Reduced 42.12%	493,990 $25.3 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $910,208 - $1.11 Million	20,800 Added 2.5%	853,490 $37.3 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $5.9 Million - $6.99 Million	126,700 Added 17.95%	832,690 $43.7 Million
Q1 2022 Apr 13, 2022	BUY	$45.75 - $56.69 $9.59 Million - $11.9 Million	209,520 Added 42.2%	705,990 $36.5 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $111,320 - $126,108	-3,100 Reduced 0.62%	496,470 $19.4 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $358,343 - $404,139	10,700 Added 2.19%	499,570 $18.1 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $669,400 - $851,200	-20,000 Reduced 3.93%	488,870 $18 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $701,675 - $823,225	22,100 Added 4.54%	508,870 $18.7 Million
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $10 Million - $14.3 Million	-371,500 Reduced 43.28%	486,770 $15.9 Million
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $121,804 - $138,232	-3,700 Reduced 0.43%	858,270 $33.6 Million
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $711,531 - $922,647	-21,900 Reduced 2.48%	861,970 $31 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $2.8 Million - $3.14 Million	75,700 Added 9.37%	883,870 $38.3 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $11,250 - $12,360	-300 Reduced 0.04%	808,170 $34.3 Million
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $3.21 Million - $3.66 Million	83,500 Added 11.52%	808,470 $35.3 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $600,467 - $728,330	-17,420 Reduced 2.35%	724,970 $31.9 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $105,535 - $112,511	-3,200 Reduced 0.43%	742,390 $26.9 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $6.07 Million - $7.04 Million	190,300 Added 34.27%	745,590 $26.5 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $17.2 Million - $19 Million	555,290	555,290 $19.8 Million

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.

Account